Strs Ohio Global Blood Therapeutics, Inc. Transaction History

Strs Ohio

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 27, 2022	BUY	$32.4 - $68.18 $385,560 - $811,342	11,900 New	11,900 $810,000
Q3 2020 Dec 14, 2020	SELL	$52.76 - $74.49 $517,681 - $730,895	-9,812 Closed	0 $0
Q2 2020 Jul 23, 2020	BUY	$48.73 - $81.82 $122,409 - $205,531	2,512 Added 34.41%	9,812 $619,000
Q1 2020 Apr 23, 2020	SELL	$41.72 - $87.2 $29,204 - $61,040	-700 Reduced 8.75%	7,300 $372,000
Q4 2019 Jan 24, 2020	BUY	$45.7 - $81.86 $91,400 - $163,720	2,000 Added 33.33%	8,000 $635,000
Q3 2019 Oct 21, 2019	SELL	$45.35 - $57.91 $9,070 - $11,582	-200 Reduced 3.23%	6,000 $291,000
Q2 2019 Jul 25, 2019	BUY	$52.6 - $63.29 $120,980 - $145,567	2,300 Added 58.97%	6,200 $326,000
Q1 2019 Apr 19, 2019	BUY	$39.99 - $53.48 $91,977 - $123,004	2,300 Added 143.75%	3,900 $206,000
Q4 2018 Jan 23, 2019	BUY	$31.54 - $46.67 $50,464 - $74,672	1,600 New	1,600 $65,000

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

Stay updated on Strs Ohio with notifications on news.